2020
DOI: 10.1111/aos.14728
|View full text |Cite
|
Sign up to set email alerts
|

Improved performance and safety from Argus II retinal prosthesis post‐approval study in France

Abstract: To evaluate the post-approval long-term outcomes of the Argus II Retinal Prosthesis, with a specific focus on its functional visual benefit in patients' daily activities. Methods: Eighteen patients with bare light perception due to end-stage retinitis pigmentosa were included in a French prospective, multicentre, single-arm study and followed for 2 years. Visual benefit in patients' daily activities was monitored through the use of the Functional Low-vision Observer Rated Assessment (FLORA), and the final scor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 24 publications
3
8
0
Order By: Relevance
“…Two further tasks in the “Daily Life” domain (Task 22, identify top step/bottom step, and Task 23, negotiate stairways independently) were also already “easy” with the device OFF and had no additional benefit with the device ON. This agrees with the Argus II studies, 18 , 19 where two of these three tasks were actually found to be easier with device OFF (travel within home independently, identify top step/bottom step) in the initial study. Notably, for the Alpha AMS data, the activity of daily living that was most positively affected by the implant was reported to be “walking in familiar areas.” 23 However, it is hard to make a direct comparison of navigation outcomes in familiar environments using different testing tools.…”
Section: Discussionsupporting
confidence: 89%
See 4 more Smart Citations
“…Two further tasks in the “Daily Life” domain (Task 22, identify top step/bottom step, and Task 23, negotiate stairways independently) were also already “easy” with the device OFF and had no additional benefit with the device ON. This agrees with the Argus II studies, 18 , 19 where two of these three tasks were actually found to be easier with device OFF (travel within home independently, identify top step/bottom step) in the initial study. Notably, for the Alpha AMS data, the activity of daily living that was most positively affected by the implant was reported to be “walking in familiar areas.” 23 However, it is hard to make a direct comparison of navigation outcomes in familiar environments using different testing tools.…”
Section: Discussionsupporting
confidence: 89%
“…The combined quantitative and qualitative data suggests the suprachoroidal device provides real-world benefit. The positive impacts of the device in activities of daily living are similar to those reported in studies with the FLORA instrument in Argus II patients 18 , 19 and with the Modified Turano Independent Mobility Questionnaire in Alpha AMS patients. 23 Hence, our real-world assessment of the suprachoroidal retinal prosthesis with the FLORA tool supports our interim laboratory-based orientation and mobility results showing that device ON performs better than the device OFF in high-contrast indoor conditions (Kolic M. et al, IOVS, 2021, 62, ARVO E-Abstract).…”
Section: Discussionsupporting
confidence: 80%
See 3 more Smart Citations